Role of pomegranate and citrus fruit juices in colon cancer prevention

World Journal of Gastroenterology

Volumn 20, Issue 16, 2014, Pages 4618-4625

  Jaganathan, Saravana Kumar ^a,b   Vellayappan, Muthu Vignesh ^b   Narasimhan, Gayathri ^b   Supriyanto, Eko ^a  

^a UNIVERSITI TEKNOLOGI MALAYSIA   (Malaysia)

^b PSNA COLLEGE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Chemoprevention; Citrus fruits; Colon cancer; Fruit juices; Pomegranate

Indexed keywords

APIGENIN; BETA CRYPTOXANTHIN; CYCLOOXYGENASE 2; ELLAGIC ACID; ELLAGITANNIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GLUTATHIONE TRANSFERASE; HESPERETIN; HESPERIDIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIMONOID; LUTEOLIN; NARINGENIN; NOBILETIN; POLYPHENOL DERIVATIVE; PROSTAGLANDIN E2; PUNICALAGIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UROLITHIN; ANTINEOPLASTIC AGENT;

ABERRANT CRYPT FOCUS; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BIOAVAILABILITY; BIOCHEMICAL COMPOSITION; CHEMOPROPHYLAXIS; CITRUS FRUIT JUICE; COLON CANCER; DRUG DETOXIFICATION; FRUIT JUICE; HUMAN; IC 50; IN VITRO STUDY; NONHUMAN; POMEGRANATE JUICE; PROTEIN EXPRESSION; REVIEW; SATSUMA; ANIMAL; BEVERAGE; CITRUS; COLONIC NEOPLASMS; FRUIT; LYTHRACEAE; MEDICINAL PLANT; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYTOTHERAPY; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; BEVERAGES; CELL LINE, TUMOR; CITRUS; COLONIC NEOPLASMS; FRUIT; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; PUNICACEAE;

EID: 84899626238     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i16.4618     Document Type: Review

References (47)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66. [PMID: 17237035 DOI: 10.1016/j.bbcan.2007.12.001]
2. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323: 1664-1672. [PMID: 2172820 DOI: 10.1056/ NEJM199012133232404]
3. Newmark HL, Lipkin M, Maheshwari N. Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (series 2). Am J Clin Nutr 1991; 54: 209S-214S. [PMID: 2053564]
4. Risio M, Lipkin M, Newmark H, Yang K, Rossini FP, Steele VE, Boone CW, Kelloff GJ. Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res 1996; 56: 4910-4916. [PMID: 8895743]
5. Johnson IT. New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat Res 2004; 551: 9-28. [PMID: 15225578 DOI: 10.1016/j.mrfmmm.2004.02.017]
6. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78: 559S-569S. [PMID: 12936950]
7. Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T. Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci 2004; 95: 481-486. [PMID: 15182427 DOI: 10.1111/j.1349-7006.2004.tb03236.x]
8. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/ World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 1999; 15: 523-526. [PMID: 10378216 DOI: 10.1016/S0899-9007(99)00021-0]
9. Gossé F, Guyot S, Roussi S, Lobstein A, Fischer B, Seiler N, Raul F. Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis 2005; 26: 1291-1295. [PMID: 15790589 DOI: 10.1093/carcin/bgi074]
10. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007; 18: 427-442. [PMID: 17321735 DOI: 10.1016/j.jnutbio.2006.11.004]
11. Adhami VM, Khan N, Mukhtar H. Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer 2009; 61: 811-815. [PMID: 20155621 DOI: 10.1080/016 35580903285064]
12. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 2000; 48: 4581-4589. [PMID: 11052704 DOI: 10.1021/jf000404a]
13. Barch DH, Rundhaugen LM, Stoner GD, Pillay NS, Rosche WA. Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogenesis 1996; 17: 265-269. [PMID: 8625448 DOI: 10.1093/carcin/17.2.265]
14. Cerdá B, Llorach R, Cerón JJ, Espín JC, Tomás-Barberán FA. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr 2003; 42: 18-28. [PMID: 12594538 DOI: 10.1007/s00394-003-0396-4]
15. Kasimsetty SG, Bialonska D, Reddy MK, Ma G, Khan SI, Ferreira D. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J Agric Food Chem 2010; 58: 2180-2187. [PMID: 20112993 DOI: 10.1021/jf903762h]
16. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 2005; 16: 360-367. [PMID: 15936648 DOI: 10.1016/j.jnutbio.2005.01.006]
17. Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R, Ramachandran C, Rabi T, Kaplan B, Lansky E. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 2002; 71: 203-217. [PMID: 12002340 DOI: 10.1023/ A:1014405730585]
18. Sheu ML, Chao KF, Sung YJ, Lin WW, Lin-Shiau SY, Liu SH. Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cell Signal 2005; 17: 975-984. [PMID: 15894170 DOI: 10.1124/mol.66.1.187]
19. Paik J, Lee JY, Hwang D. Signaling pathways for TNFainduced COX-2 expression: mediation through MAP kinases and NFkB, and inhibition by certain nonsteroidal antiinflammatory drugs. Adv Exp Med Biol 2002; 507: 503-508. [PMID: 12664632]
20. Jobin C, Morteau O, Han DS, Balfour Sartor R. Specific NFkappaB blockade selectively inhibits tumour necrosis factoralpha- induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 1998; 95: 537-543. [PMID: 9893042]
21. Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, Jetten AM. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 1999; 274: 29138-29148. [PMID: 10506169 DOI: 10.1074/ jbc.274.41.29138]
22. Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol 2004; 68: 1089-1100. [PMID: 15313405 DOI: 10.1016/j.bcp.2004.05.031]
23. Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 2004; 38: 771-785. [PMID: 15493450 DOI: 10.1080/107157604100017278 58]
24. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 2006; 54: 980-985. [PMID: 16448212 DOI: 10.1021/jf052005r]
25. Larrosa M, Tomás-Barberán FA, Espín JC. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 2006; 17: 611-625. [PMID: 16426830 DOI: 10.1016/j.jnutbio.2005.09.004]
26. Maehama T, Dixon JE. The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998; 273: 13375-13378. [PMID: 9593664 DOI: 10.1074/jbc.273.22.13375]
27. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275: 992-998. [PMID: 10625637 DOI: 10.1074/jbc.275.2.992]
28. Schultz RM, Merriman RL, Andis SL, Bonjouklian R, Grindey GB, Rutherford PG, Gallegos A, Massey K, Powis G. In vitro and in vivo antitumor activity of the phosphatidylinositol- 3-kinase inhibitor, wortmannin. Anticancer Res 1995; 15: 1135-1139. [PMID: 7653991]
29. Boateng J, Verghese M, Shackelford L, Walker LT, Khatiwada J, Ogutu S, Williams DS, Jones J, Guyton M, Asiamah D, Henderson F, Grant L, DeBruce M, Johnson A, Washington S, Chawan CB. Selected fruits reduce azoxymethane (AOM)- induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food Chem Toxicol 2007; 45: 725-732. [PMID: 17321025 DOI: 10.1016/j.fct.2006.10.019]
30. Rosenblat M, Hayek T, Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 2006; 187: 363-371. [PMID: 16226266 DOI: 10.1016/j.atherosclerosis.200 5.09.006]
31. Tanaka T, Tanaka T, Tanaka M, Kuno T. Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin. J Biomed Biotechnol 2012; 2012: 516981. [PMID: 22174562 DOI: 10.1155/2012/516981]
32. Tanaka T, Sugiura H, Inaba R, Nishikawa A, Murakami A, Koshimizu K, Ohigashi H. Immunomodulatory action of citrus auraptene on macrophage functions and cytokine production of lymphocytes in female BALB/c mice. Carcinogenesis 1999; 20: 1471-1476. [PMID: 10426794 DOI: 10.1093/ carcin/20.8.1471]
33. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, Malone WF, Hawk ET, Sigman CC. New agents for cancer chemoprevention. J Cell Biochem Suppl 1996; 26: 1-28. [PMID: 9154166]
34. Mori H, Sugie S, Yoshimi N, Hara A, Tanaka T. Control of cell proliferation in cancer prevention. Mutat Res 1999; 428: 291-298. [PMID: 10518001 DOI: 10.1016/S1383-5742(99)00055-1]
35. Surh YJ. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr 2008; 17 Suppl 1: 269-272. [PMID: 18296353]
36. Frydoonfar HR, McGrath DR, Spigelman AD. The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin. Colorectal Dis 2003; 5: 149-152. [PMID: 12780904 DOI: 10.1046/j.1463-1318.2003.00444.x]
37. Tian Q, Miller EG, Ahmad H, Tang L, Patil BS. Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer 2001; 40: 180-184. [PMID: 11962254 DOI: 10.1207/S15327914NC402_15]
38. Pan MH, Chen WJ, Lin-Shiau SY, Ho CT, Lin JK. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002; 23: 1677-1684. [PMID: 12376477 DOI: 10.1093/carcin/23.10.1677]
39. Au A, Li B, Wang W, Roy H, Koehler K, Birt D. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models. Nutr Cancer 2006; 54: 243-251. [PMID: 16898869 DOI: 10.1207/s15327914nc5402_11]
40. Aranganathan S, Selvam JP, Nalini N. Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogeninduced aberrant crypt foci in colon cancer rats: a dose-dependent study. J Pharm Pharmacol 2008; 60: 1385-1392. [PMID: 18812032 DOI: 10.1211/jpp/60.10.0015]
41. Hoensch H, Groh B, Edler L, Kirch W. Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J Gastroenterol 2008; 14: 2187-2193. [PMID: 18407592 DOI: 10.3748/]
42. Vanamala J, Leonardi T, Patil BS, Taddeo SS, Murphy ME, Pike LM, Chapkin RS, Lupton JR, Turner ND. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis 2006; 27: 1257-1265. [PMID: 16387741 DOI: 2006]
43. Kohno H, Yoshitani S, Tsukio Y, Murakami A, Koshimizu K, Yano M, Tokuda H, Nishino H, Ohigashi H, Tanaka T. Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Life Sci 2001; 69: 901-913. [PMID: 11488403 DOI: 10.1016/ S0024-3205(01)01169-9]
44. Hanske L, Loh G, Sczesny S, Blaut M, Braune A. The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J Nutr 2009; 139: 1095-1102. [PMID: 19403720 DOI: 10.3945/jn.108.102814]
45. Leonardi T, Vanamala J, Taddeo SS, Davidson LA, Murphy ME, Patil BS, Wang N, Carroll RJ, Chapkin RS, Lupton JR, Turner ND. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane- treated rats. Exp Biol Med (Maywood) 2010; 235: 710-717. [PMID: 20511675 DOI: 10.1258/ebm.2010.009359]
46. Wendum D, Masliah J, Trugnan G, Fléjou JF. Cyclooxygenase- 2 and its role in colorectal cancer development. Virchows Arch 2004; 445: 327-333. [PMID: 15340847 DOI: 10.1007/ s00428-004-1105-2]
47. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 2006; 12: 4018-4026. [PMID: 16818701 DOI: 10.1158/1078-0432.CCR-05-2290]